Physician profile
Adam J Ringler
NPI 1407813082
$11,355.97
in general payments reported to CMS, 2019-2025
45 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $1,299 · 2021: $620 · 2022: $2,973 · 2023: $1,038 · 2024: $4,215 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $3,750 · Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $3,750.00 |
| Food and Beverage | $1,730.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $3,767.77 | 2022-2024 | Restrata Wound Matrix |
| Medical Device Business Services, INC. | $1,696.50 | 2022 | |
| Organogenesis INC. | $995.46 | 2019-2023 | Puraply |
| Stryker Corporation | $720.55 | 2019-2024 | Salvation, N/A, Variax |
| Arthrex, INC. | $715.26 | 2020 | |
| Smith+Nephew, INC. | $658.38 | 2019-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Depuy Synthes Sales INC. | $360.60 | 2019-2023 | Hammerlock |
| Wright Medical Technology, INC. | $220.62 | 2019-2020 | |
| Abbvie INC. | $215.34 | 2022 | |
| Cardiovascular Systems INC. | $205.72 | 2019-2021 | |
| Ets Wound Care LLC | $181.08 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Innovation Technologies INC | $136.03 | 2022-2023 | Irrisept |
| Paratek Pharmaceuticals, INC. | $125.90 | 2020-2025 | Nuzyra, Xhance |
| Sebela Pharmaceuticals INC. | $121.24 | 2020-2023 | Naftin |
| Kci USA, INC. | $119.03 | 2020-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $112.62 | 2020-2024 | Integra, Tenoglide, Primatrix |
| Metric Medical Devices, INC. | $104.56 | 2022-2023 | Super Staple, Super Scaffold |
| Triad Life Sciences INC. | $95.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $89.63 | 2019-2020 | |
| Medtronic Vascular, INC. | $71.49 | 2019 | |
| Djo, LLC | $54.95 | 2024-2025 | Cmf |
| Urgo Medical North America, LLC | $50.02 | 2023-2025 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Solventum Corporation | $46.06 | 2024-2025 | Kerramax Care, Activ.A.C., Promogran Prisma |
| Averitas Pharma INC. | $41.32 | 2023-2024 | Qutenza |
| Polynovo North America LLC | $36.16 | 2025 | Novosorb Btm |
| Convatec INC. | $35.65 | 2024 | |
| Horizon Therapeutics Plc | $32.96 | 2021-2022 | |
| Ibsa Pharma INC. | $28.93 | 2023-2024 | Tirosint, Licart, Licart |
| Kowa Pharmaceuticals America, INC. | $27.02 | 2022 | |
| Kerecis Limited | $24.78 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Osiris Therapeutics INC. | $23.99 | 2019 | |
| Reprise Biomedical, INC. | $23.13 | 2024 | Miro3d |
| Grt US Holding, INC. | $22.11 | 2022 | |
| Treace Medical Concepts, INC. | $20.04 | 2024 | |
| Glenmark Therapeutics INC. | $20.00 | 2019 | |
| Melinta Therapeutics, LLC | $18.77 | 2019 | |
| Acell, INC. | $18.73 | 2019 | |
| Bioventus LLC | $18.10 | 2021 | |
| Stimwave Technologies Incorporated | $16.00 | 2021 | |
| Cashflow Solutions, LLC | $15.51 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Misonix INC | $15.30 | 2019 | |
| Rikco International, LLC | $14.87 | 2019 | |
| Amniox Medical, INC. | $14.67 | 2019 | |
| Aroa Biosurgery Incorporated | $12.20 | 2022 | |
| Biocomposites INC | $11.90 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Ringler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.